A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

It’s difficult to fathom that the health of half the world’s population is underserved. But it’s a hard truth. There are many conditions that disproportionately impact women. Other conditions and ...

Eli Lilly and Co., Gates Ventures, GORE, Impulse Dynamics, Indiana University, Novartis, Olio Labs, Stryker, University of Texas Health Science Center at San Antonio, and others. These organizations ...

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...

Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP), a wholly owned subsidiary of U.S.-based Eli Lilly and Company (Lilly), today announced the establishment of a SGD$42 ...

It can range from mild to utterly disabling, and there are no proven diagnostic tests or treatments, although scientists have ...

INDIANAPOLIS—As lawmakers and leaders in education prepare for what could be a contentious budget session, the Indiana ...

In a report released yesterday, Evan Seigerman from BMO Capital maintained a Buy rating on Schrodinger (SDGR – Research Report), with a ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

U.S. policies that fix the IRA, strengthen patents, and incentivize antimicrobial research could help hasten new medicines ...

Most of our scientists, the thousand people who work here ... Just any any advice to us when we start to look at longevity ...